Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
about
Vaccines for preventing typhoid feverCombined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmissionEntirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune ResponsesVaccines against invasive Salmonella disease: current status and future directionsVaccines against enteric infections for the developing worldSalmonella as a model for non-cognate Th1 cell stimulationA review of typhoid fever transmission dynamic models and economic evaluations of vaccinationRethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areasDevelopment of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharideIdentification of a common immune signature in murine and human systemic Salmonellosis.Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agendaHigh-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata.Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.B cells as a critical node in the microbiota-host immune system network.Flagella overexpression attenuates Salmonella pathogenesisHaloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine developmentAn adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trialDirect visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.Enteric fever in two vaccinated travellers to Latin America.Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.Identifying an immune signature against invasive SalmonellaDevelopment of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.Effectiveness of typhoid vaccination in US travelers.Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network.Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion.Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteriaMHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection.The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice.A one-step homogeneous sandwich immunosensor for Salmonella detection based on magnetic nanoparticles (MNPs) and quantum Dots (QDs).Contaminated water delivery as a simple and effective method of experimental Salmonella infectionSalmonella Infection Enhances Erythropoietin Production by the Kidney and Liver, Which Correlates with Elevated Bacterial BurdensKinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal.Salmonella enterica serovar Typhimurium mutants completely lacking the F(0)F(1) ATPase are novel live attenuated vaccine strains.Vaccines and biosimilarity: a solution or a problem?
P2860
Q24201238-D82FB821-DE10-42C3-985E-AA9922A518A4Q24621347-995EB7A1-F848-48ED-8828-E51FC9CC3D11Q26746887-95051AA1-51A7-41A0-B72B-65728A7821CFQ27007088-28A1B42B-BE54-4649-8581-340FCD9F5688Q28080866-3B42C327-432B-44E1-8343-87594519F49AQ28082931-5FBEC32C-D1FB-4547-9E91-396E9D94E93FQ28088491-F0591396-4FA6-4D95-9C7D-81D0F24BB67BQ28308143-EB10529B-E22F-4165-91C2-9F9EDD3224A3Q28394220-33AEE413-DF87-46D5-9E68-BE97B3027FDAQ30424877-5F51028C-CA1E-4406-9494-784D3968E239Q30427484-37827510-5F67-4405-8259-6577270803AEQ33690625-39E5C67A-2940-4A23-8884-BE3C7CA757CDQ33855197-CC3FF66C-DD33-4468-9677-12D02D81BCC9Q34150129-9E931771-98CF-40DD-847B-57D811C324FBQ34179527-A6037C04-61C8-4254-9513-6D60B23AF294Q34425515-FD27789C-97C5-4EA2-8973-A3CE8DFE07DEQ34442222-483ED9E3-F9F0-4773-920E-DA3B5C18EDC2Q34515009-7049CF63-5FEB-4182-9D29-EFADE896EB5DQ34602404-7AEEDB0C-10A5-4A5A-897F-74EE611F7B95Q34669382-9CD799B5-8300-4840-BC23-4C70048AB97BQ34673466-76DDF519-8EB5-48C3-9B16-C5A956613AE1Q35071000-9FEF164C-B4F9-455A-A579-E9810B4F4C56Q35344179-6EC0EA52-5FB2-464E-AEC9-96AAC6369000Q35626884-A4F82D73-7211-45B6-AFA7-B6ED1A305CE0Q35798947-14E56DE8-346C-4127-BBEC-D2A199214301Q35882563-C07F3CD6-D007-4008-827A-852C2092BEFDQ36145803-CF12AA16-6366-492C-923E-48054EAEC03BQ36159616-196D2000-2D7C-46F0-B69A-CFCC830C0D2CQ36238036-F94E3B0F-BFAB-4BCB-8C36-D3F84708FA50Q36456788-64D058E2-2318-4C34-9A8C-E09E546BC84AQ36509587-F8BB929F-0513-40CF-AA8A-0D81AA67CC55Q36518258-8233C1F0-1AF2-4A48-B96E-D237DADF3614Q36708987-007CB2EF-0B9B-4762-8F1E-AD24C02F0638Q36743817-0FC0E5C9-287F-4472-9A2E-57A344151928Q36820628-4ECDC605-3D8C-4AA9-AE32-561E60A90998Q37088080-C9C60466-8C35-4507-A128-DB8542E27A02Q37287154-11D57B4F-A7BE-4FA0-8F8B-8F911B077ACAQ37374692-625BC52E-2100-4ACD-9F7C-8C2B185A278AQ37504399-221EED49-E592-484F-810F-3F6C4CBEF1D4Q37608322-D9EEC75F-A3D1-4F09-8467-762E35EED40E
P2860
Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Typhoid fever vaccines: system ...... randomised controlled trials.
@en
type
label
Typhoid fever vaccines: system ...... randomised controlled trials.
@en
prefLabel
Typhoid fever vaccines: system ...... randomised controlled trials.
@en
P50
P1433
P1476
Typhoid fever vaccines: system ...... randomised controlled trials.
@en
P2093
Camilo J Acosta
Elad Goldberg
P304
P356
10.1016/J.VACCINE.2007.08.027
P407
P577
2007-09-04T00:00:00Z